Prime

Kenya joins the WHO vaccine technology transfer programme

Kenya BioVax Institute CEO Dr Michael Lusiola (left) showing an architectural plan model to the World Bank Vice President for Human Development Mamta Murthi (centre) and State Department for Medical Services Permanent Secretary Harry Mutai when they toured Kenya BioVax Institute in Embakasi, Nairobi on February 7,2024.

Photo credit: File | Nation Media Group

By  Linet Owoko

Correspondent

Nation Media Group


Kenya is among six African countries selected to participate in the World Health Organisation (WHO) and Medicines Patent Pool (MPP) mRNA Technology Transfer Programme, an initiative that aims to shift vaccine production from wealthy nations to countries that need them most.

Related

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. PRIME Local contractors sue State over tax breaks for Chinese firms

  2. When grief becomes art: The painter who puts raw feelings on canvas

  3. PRIME Kenya Power cuts supplier late payment penalties to Sh290m

  4. PRIME Africa Spirits wins ‘Glen’ whisky brand war against Scotch Whisky Association

In the headlines

View All